BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19943856)

  • 1. Expression of tenascin and nucleolar organizer region in ameloblastoma and ameloblastic fibroma.
    Carnelio S; Vij H
    J Oral Pathol Med; 2010 Mar; 39(3):223-9. PubMed ID: 19943856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in selected odontogenic lesions.
    Eslami B; Yaghmaei M; Firoozi M; Saffar AS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):187-92. PubMed ID: 12582359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophilic nucleolar organizer regions (AgNORs) in odontogenic myxoma (OM) and ameloblastic fibroma (AF).
    Martins C; Carvalho YR; do Carmo MA
    J Oral Pathol Med; 2001 Sep; 30(8):489-93. PubMed ID: 11545240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of tenascin and fibronectin in odontogenic tumours and human fetal tooth germs.
    Nagai N; Yamachika E; Nishijima K; Inoue M; Shin HI; Suh MS; Nagatsuka H
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):191-5. PubMed ID: 7522711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameloblastoma and its relationship to ameloblastic fibroma: their histogenesis based on an unusual case and review of the literature.
    Chen SH; Katayanagi T; Osada K; Hamano H; Inoue T; Shimono M; Takano N; Shigematsu T
    Bull Tokyo Dent Coll; 1991 May; 32(2):51-6. PubMed ID: 1819443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal gene expression in normal and neoplastic human odontogenic epithelia.
    Heikinheimo K; Sandberg M; Happonen RP; Virtanen I; Bosch FX
    Lab Invest; 1991 Dec; 65(6):688-701. PubMed ID: 1721670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ploidy status using flow cytometry and nucleolar organizer regions in benign and malignant epithelial odontogenic tumors.
    Mohamed Mahmoud SA; El-Rouby DH; El-Ghani SF; Badawy OM
    Arch Oral Biol; 2017 Jun; 78():94-99. PubMed ID: 28222389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma.
    Yoon HJ; Jo BC; Shin WJ; Cho YA; Lee JI; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):767-76. PubMed ID: 22014999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Odontogenic tumors: analysis of 706 cases.
    Regezi JA; Kerr DA; Courtney RM
    J Oral Surg; 1978 Oct; 36(10):771-8. PubMed ID: 280645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A quantitatively pathological study on malignant ameloblastomas].
    Liu J; Wang S; Chen X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun; 20(3):187-9. PubMed ID: 12600062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of extracellular matrix proteins in odontogenic tumours and developing teeth.
    Heikinheimo K; Morgan PR; Happonen RP; Stenman G; Virtanen I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):101-9. PubMed ID: 1720587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of odontogenic mixed tumours.
    Yamamoto K; Yoneda K; Yamamoto T; Ueta E; Osaki T
    Eur J Cancer B Oral Oncol; 1995 Mar; 31B(2):122-8. PubMed ID: 7543314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
    Müller S; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed odontogenic tumors in children and adolescents.
    Gyulai-Gaál S; Takács D; Szabó G; Suba Z
    J Craniofac Surg; 2007 Nov; 18(6):1338-42. PubMed ID: 17993878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of 318 odontogenic tumors in Kaduna, Nigeria.
    Adebayo ET; Ajike SO; Adekeye EO
    J Oral Maxillofac Surg; 2005 Jun; 63(6):811-9. PubMed ID: 15944979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.